Smartwatch safety net for leptomeningeal metastasis
Part of Brain & nervous system, Cancer clinical trials.
This trial tests whether a smartwatch app can track symptoms in people with leptomeningeal metastasis (cancer spread to the fluid around the brain and spinal cord) and send alerts when things change. It aims to improve care by catching problems early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with leptomeningeal metastasis from any type of cancer.
- You are currently getting cancer treatment or being monitored for this condition.
- You are 18 years or older.
- You are able to take care of yourself at least 50% of the time (Karnofsky score of 50 or higher).
- You have a compatible smartphone (iPhone with iOS 16+ or Android) and are willing to wear a smartwatch for at least 10 hours a day.
- You can give informed consent, or have someone who can consent for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study watches and writes down how patients with cancer that has spread to the brain or spinal cord lining (leptomeningeal metastases) are doing. It helps doctors learn more about this condition without giving any new treatments.
This study uses a smartwatch to monitor your activity and recovery after treatment for sarcoma or bone cancer in your leg or pelvis. It helps your care team keep track of how you're doing from home.
This study tests whether patients in early-phase cancer trials can comfortably use smartwatches and phone apps to track their health and report how they're feeling. The goal is to see if these tools can help doctors better understand how cancer treatments affect daily life.
This study tests whether using a smartwatch to track daily activity can encourage more movement and help manage symptoms like weakness, numbness, or memory problems in people receiving cancer treatment for a brain tumor.
This trial uses an Apple Watch and a smartphone app to track health data and detect early signs of infection in children and teens getting cancer treatment. The goal is to catch problems early so they can be treated quickly.
This study uses a smartphone app and a wearable watch to track your symptoms and daily activity. The information may help doctors better understand and manage MPN, and could lead to improved care.
Hear when a new Leptomeningeal Metastasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.